Back to
JPMorgan Chase & Co.
TORCN
6 quarters
Position history for
JPMorgan Chase & Co.'s holdings in ADICET BIO INC
As of its Q3 2025 13F, JPMorgan Chase held 771 shares of TORCN (Adicet Bio), worth $625. JPMorgan Chase's 13F filings listed TORCN from Q3 2024 to Q3 2025, 5 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$115,708
Total Shares Change
-80,353
Quarter-by-Quarter History
Other major holders of TORCN: RTW Investments, LP